INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET-amplified NSCLC

Поділитися
Вставка
  • Опубліковано 27 вер 2024
  • In the latest Publication Perspective by The Video Journal of Biomedicine, Egbert Smith discusses a recent article published in Future Oncology, titled 'INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance'.
    Subscribe: www.youtube.co....
    Visit The Video Journal of Biomedicine: www.biomedicin...
    Follow us on Twitter: / vjofbiomedicine
    LinkedIn: / vide. .
    Facebook: / videojournal. .
    Watch here: www.futuremedi...
    #INSIGHT2 #NSCLC #LungCancer

КОМЕНТАРІ •